接种疫苗的麻疹病例是否对重症具有保护作用?
该研究纳入法国2006年至2019年中旬报告的10,399例≥2岁且1980年后出生的麻疹病例,采用多项逻辑回归计算调整相对危险度(aRR),评估不同剂次与末次接种后时间对重症麻疹的疫苗有效性。结果显示,两剂接种者发生重症麻疹的风险较未接种者分别降低71%(末次接种后不足15年,aRR=0.29,95%CI 0.12-0.72)和83%(超过15年,aRR=0.17,95%CI 0.04-0.70),中度疾病风险呈相似模式。结论强调两剂麻疹疫苗可提供针对重症的长期保护,即使发生疫苗失败。
要点
- 两剂麻疹疫苗接种者重症风险较未接种者降低71%–83%。
- 末次接种后超过15年仍显示对重症的长期保护。
- 中度麻疹风险随接种剂次呈现与重症相似的保护模式。
核心结论
- 两剂麻疹疫苗接种对重症麻疹提供长期保护,即使发生疫苗失败。
- 应遵守推荐的麻疹疫苗接种程序以预防重症病例。
研究设计与样本
- 纳入法国2006年至2019年中旬报告的麻疹病例,年龄≥2岁且1980年后出生,共10,399例。
- 采用多项逻辑回归计算调整相对危险度(aRR),评估不同剂次和末次接种后时间与重症麻疹的关联。
主要发现
- 两剂接种者重症麻疹风险较未接种者降低71%(末次接种后不足15年,aRR=0.29,95%CI 0.12-0.72)。
- 两剂接种者重症麻疹风险较未接种者降低83%(末次接种后超过15年,aRR=0.17,95%CI 0.04-0.70)。
- 中度麻疹疾病风险随接种剂次呈现与重症相似的保护模式。
临床怎么用
- 应确保按推荐程序完成两剂麻疹疫苗接种,以预防重症麻疹。
- 对疫苗接种史进行核实,尤其在重症风险评估时考虑末次接种后时间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We aimed to estimate vaccine effectiveness against severe measles based on the number of vaccine doses administered and the time since last vaccination. PATIENTS AND METHODS: We included measles cases aged at least 2 years and born since 1980 who were notified in France between 2006 and mid-2019. We considered two severity levels (moderate, severe) and calculated adjusted relative risks (aRR) using multinomial logistic regression. RESULTS: We included 10,399 cases. The risk of severe measles in two-dose vaccine recipients was 71% (aRR = 0.29 [95%CI 0.12-0.72]) and 83% (aRR = 0.17 [95%CI 0.04-0.70]) lower than in unvaccinated cases, if the time since last dose was less or more than 15 years, respectively. The risk of moderate disease followed a similar pattern. CONCLUSIONS: Two-dose measles vaccination provided long-term protection against severe cases, even after vaccine failures. These findings underscore the need for compliance to the recommended measles vaccination schedule to prevent severe cases.
引用
- Bonneton M, Antona D, Danis K, et al. Are vaccinated measles cases protected against severe disease? Vaccine. 2020. PMID: 32418790. doi:10.1016/j.vaccine.2020.05.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。